Cardiovascular Outcomes Report


2019 Innovations Reports for Cardiovascular Services

Innovations at a Glance

  • Originated the randomized multicenter ROMA trial aimed at evaluating the impact of the use of one internal thoracic artery versus two or more arterial grafts for coronary artery bypass graft.
  • Led a multicenter clinical trial finding that low-risk patients with severe aortic stenosis had a 46 percent lower risk of death, stroke, or rehospitalization when their aortic valve was replaced via TAVR versus open-heart surgery.
  • Developed a minimally invasive technique for transcarotid artery revascularization by directly accessing the carotid artery through a keyhole incision at the base of the neck.
  • Developing electromechanical wave imaging, a novel, non-invasive technology to better identify the origin of arrhythmias prior to cardiac ablation.
  • One of a handful of centers in the U.S. involved in a clinical trial to treat acute type A aortic dissections with the frozen elephant trunk graft technique.
  • Leading the international, multicenter RADIANCE-HTN SOLO and RADIANCE II trials to assess whether a device-based technique can reduce blood pressure.
  • Performed the first human case using the Conformal Left Atrial Appendage (LAA) Seal for LAA occlusion for the prevention of stroke in patients with atrial fibrillation.
  • Developed the AngioVac System, an endovascular suction device for filtering intravascular thrombi and emboli.
  • Offering the remedē® System, a newly FDA-approved phrenic nerve stimulation device for the treatment of central sleep apnea, a condition that can lead to heart failure and stroke.
  • Serving as sites for the NIH-sponsored CREST-2 trial assessing benefits of carotid stenting and endarterectomy versus intensive medical management to prevent stroke in patients with carotid stenosis who are asymptomatic.